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Background: Eating disorders or disturbed eating attitudes and behaviours (EABs) may contribute to poor nutritional status in Cystic Fibrosis (CF).
Existing measures of disturbed EABs can have different meanings in this population and do not assess CF-related EABs. A self-report measure of
EABs in CF was developed to highlight areas of eating disturbance.
Methods: The content validity of a draft measure was evaluated via expert evaluation and literature review and an amended measure piloted with
8 CF patients using cognitive interviewing. A further amended measure was administered to 155 CF patients (11–62 years) attending CF clinics.
Results: Principal components analyses revealed a three-factor structure (‘Desire for thinness and weight loss’, ‘Disturbed EABs’, and ‘Appetite’)
with good internal consistencies for subscales and the 21-item whole measure.
Conclusions: The measure looks promising as a tool to highlight EAB disturbance in CF. Further work will establish its construct validity and
clarify interpretation of subscales.
© 2012 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Eating; Cystic ﬁbrosis; Eating disorder1. Introduction
Eating disorders (EDs) or disturbed eating attitudes or
behaviours (EABs) have been reported in young people [1–3]
and adults [4–6] with Cystic Fibrosis (CF) and may contribute to
poor nutritional status, which is associated with poor growth and
delayed puberty [7], reduced lung function [8] and decreased
survival [9]. It will be valuable to assess disturbances in EABs in
the CF population; however, existing self-report measures of
disturbed EABs (i.e. [10–12]) are not wholly appropriate for this
population. For example, some questions can reflect consequences
of CF or treatment guidelines rather than eating psychopathology,
such as eating a high calorie diet and showing preoccupation with
food/calories due to dietary recommendations. Existing measures
also do not assess EABs related to the CF disease process or
treatment regimen likely to be associated with poor nutritional
status, such as feeling full easily or not taking enzymes or insulin⁎ Corresponding author. Tel.: +44 20 7829 8896; fax: +44 20 7829 7846.
E-mail address: mandy.bryon@gosh.nhs.uk (M. Bryon).
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doi:10.1016/j.jcf.2012.05.005for weight control. Some adaptations to an existing eating dis-
orders measure [10] have been made based on a different factor
structure being observed in an adult CF sample [4]; however, this
does not allow for the assessment of CF-related EABs, as above.
A draft version of a self-report measure of EABs in CF was
developed by Bryon [13]; this is subsequently referred to in this
article as the draft CFEAB measure. This had 29 items and was
aimed at patients aged 11 and over given the peak incidence of
EDs in adolescence [14] and that eating problems in CF tend to
decline from the teenage years onwards [15]. This measure
assessed EABs associated with anorexic and bulimic psychopa-
thology along with CF-related EABs that may impact on eating or
weight. Although body image can impact on EABs, it was felt an
assessment of body image was beyond the scope of this brief
measure [13], particularly as body image in CF can be com-
plicated by non eating-related issues (e.g. clubbing). Items were
developed based on previous research findings [1], EDs diag-
nostic criteria [16] and clinical experience with patients with CF.
Items assessing self-esteem were included since self-esteem has
been highly correlated with disturbed EABs [17] although theseby Elsevier B.V. All rights reserved.
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construct. A 5-point Likert scale (Never–Always) was used.
The current study aimed to further develop and evaluate this
draft measure in accordance with standard scale development
recommendations [18]. The content validity of items was first
evaluated via consultation with experts in the field and a
literature review of target constructs. An amended CFEAB
measure was then piloted with eight participants with CF using
cognitive interviewing as an assessment of the measure's
practical acceptability and ease of understanding [19]. Finally,
a further amended CFEAB measure was administered to a large
sample of participants with CF (n=155) to assess its factor
structure and internal consistency.2. Methods
2.1. Setting
Participants were recruited from three hospital CF clinics
(two paediatric, one adult) at two Specialist CF Centres in
central London. Ethical approval was obtained from relevant
NHS and university bodies.2.2. Review of the draft CFEAB measure's content validity
2.2.1. Expert review
An evaluation form was designed that assessed each of the
items' relevance in the measure and their comprehensibility on
a 5-point scale (1 = ‘Not at all relevant/understandable’, 5 =
‘Very relevant/understandable’) and included space for quali-
tative comments and to identify EABs in CF that had been
omitted from the measure. 25 health-care professionals (5 from
the adult team, 20 from paediatric teams) were invited along
with a service-user representative from the CF Trust (a national
CF charity and service monitoring organisation). The final
sample included 8 health-care professionals (3 paediatric
consultants, 1 paediatric specialist nurse, 2 psychologists (1
adult, 1 paediatric) and 2 dieticians (1 adult, 1 paediatric)) and 1
service-user.2.2.2. Literature review
A current literature review of the measurement of disturbed
EABs and the presence of disturbed EABs in CF was completed.
Keyword searches (‘disturbed EABs’, ‘EDs’, ‘subclinical EDs’,
‘partial syndrome EDs’, ‘disordered eating’, ‘eating’, ‘eating
problems’ and ‘measure/s’, ‘measurement’, ‘questionnaire’,
‘assessment’ or ‘cystic fibrosis’) were carried out on empirical
databases including PubMed, PsychInfo, Science Direct, JSTOR
and Google Scholar.
The research team (Trainee Clinical Psychologist, two
Clinical Psychologists) then met to review the findings of the
expert evaluation and literature review and implications for
amendments to the draft CFEAB measure; following amend-
ments, this was termed ‘amended CFEAB measure #1’.2.3. Cognitive interviewing study: piloting of amended CFEAB
measure #1
During a cognitive interview, participants are asked to ‘think
aloud’whilst completing a questionnaire, describing their thought
processes during comprehension and the response process, whilst
interviewers ask relevant follow-up or planned probe questions
to further evaluate this. Data from these interviews can help
researchers to formulate or amend questions so they better or
more clearly access targeted constructs. In the current study,
interviews lasted a maximum of 45 min. Written informed
consent/assent was obtained from all participants. Following
guidelines in Willis [19], digital recordings of the cognitive
interviews were reviewed and notes made regarding any dif-
ficulties participants experienced with comprehension or the
response process. A written report summarising these was re-
viewed by the research team and amendments made to the
amended CFEAB measure #1, which was then termed ‘amended
CFEAB measure #2’.
2.3.1. Measures
The amended CFEABmeasure #1 comprised of 22 statements
relating to EABs in CF. For each statement, participants were
asked to choose which word best applies to them from a 5 point
Likert-scale (Never, Rarely, Sometimes, Often, and Always) or to
mark ‘Never’ if an item did not apply.
2.3.2. Participants
In line with recommendations by Willis [19], a sample of
8 participants who were nominally representative of the target
wider UK CF population above 11 years was targeted. A 50–50
split between adolescents (11–16 years) and adults (17 years
and above) and males and females was targeted matching
current demographics of the UK CF population [20]. Inclusion
criteria were that participants were: aged 11–65 years and seen
in a specialist CF clinic with an established diagnosis of CF
made by a medical professional. Exclusion criteria were that
participants: were not able to speak or read English or displayed
clear evidence of a learning disability (i.e. in contact with
learning disability services) or had received a lung transplant
since patients post-transplant are not consistently managed by
CF clinics.
Eligible participants were identified from clinic lists by a
member of the clinical team. In total, 14 adults and 20 adolescents
were invited. One eligible adult was identified by the team
member as unsuitable to invite although reasons for this were
not specified to maintain confidentiality. The sample obtained
included 8 participants: 4 adolescents (2 females (11 and
14 years) and 2 males (11 and 16 years)) and 4 adults (2 females
and 2 males, 24–34 years).
2.4. Psychometric study: administration of amended CFEAB
measure #2 to large sample
Participants completed the amended CFEAB measure #2
during their CF clinic visit, at a time convenient to them. Written
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allocated a code number to maintain confidentiality.2.4.1. Measures
The amended CFEABmeasure #2 comprised of 24 statements
relating to EABs in CF. Response options remained the same.
Each item was scored from 0 to 4, with higher scores indicating
more disturbed EABs. Clinical and demographic data were
collected via a brief questionnaire completed by accessing
medical notes.2.4.2. Participants
A ratio of at least 5 participants per item has been
recommended when using factor analytic methods to develop a
psychometric measure, with a 10:1 ratio thought to represent
a more ‘ideal’ scenario [21]. A sample of 150 that was
representative of the target UK CF population above 11 years in
terms of age and gender, as above, was targeted. Inclusion and
exclusion criteria were the same as above.
Eligible participants were identified from clinic lists by a
member of the clinical team. In total, 124 patients from the adult
service and 119 patients from paediatric services were invited.
Five adults were ineligible for the study (2 post-transplant, 2
learning disability, 1 not confirmed CF) and eleven identified as
unsuitable to invite although reasons for this were not specified.
Three adolescents were ineligible due to learning disabilities and
nine deemed unsuitable to invite for unspecified reasons. The
final sample included 155 participants indicating a response ratePotential pool of
Patients due to atten
recruitment ph
271 (131 adolescen
Patients not invited to take part
- Due to not meeting eligibility criteria:     
8 (3 adolescents, 5 adults)
- Due to team member identifying as 
unsuitable to invite for unspecified reasons:
20 (9 adolescents, 11 adults)
Fig. 1. Diagrammatic representation of recruitment for psychometric study. * If only p
was achieved.of 64% (62%: adolescents, 65%: adults); if only participants who
attended their clinic visit were included an 80% recruitment rate
was achieved. A diagrammatic representation of recruitment for
the psychometric study can be found in Fig. 1. Clinical and
demographic characteristics of the sample are displayed in
Table 1. The sample was representative of the wider UK CF
population above 11 years described on the UK CF Trust
Registry [20] in terms of age, gender, ethnicity, weight, lung
function, pancreatic sufficiency and use of supplementary
feeding.3. Results
3.1. Review of the draft CFEAB measure's content validity
3.1.1. Expert review
Using Lyn's [22] criteria for the number of experts who need
to agree for an item to be considered content valid (a rating of
either 3, 4, or 5 on the ‘Relevance’ question of the evaluation
form), there were 3 items on the draft CFEAB measure that did
not achieve content validity and were removed from the measure.
A number of other amendments were made based on experts'
qualitative comments. Full details of these are beyond the scope
of this paper. However, in summary, another 6 items were deleted
(including all self-esteem items) and small wording changes
made to 11 items; for example, ‘I avoid eating because my CF
makes me sick or vomit’ was changed to ‘I avoid eating because
my CF makes me feel sick’ and ‘I feel full even when my stomach
is empty’ was changed to ‘I feel full even after eating a small participants
d clinics during 
ase:       
ts, 140 adults)
Patients invited to take part
243 (119 adolescents, 124 adults) 
Final sample obtained
155 (74 adolescents, 81 adults)
Response rate:          
64% (62% adolescents, 65% adults)*
articipants who attended their clinic visit were included an 80% recruitment rate
Table 1
Clinical and demographic characteristics of the sample (N=155).
Ethnicity 95% White British
Age distribution Adolescents n=74 Median: 13 years
(11–15 years)
Adults n=81 Median: 27 years
(16–62 years)
Gender distribution Total sample 47.7% male
Adolescents 43.2% male
Adults 51.8% male
Weight Adolescents: % WFH (Range) 100.7
(78.1–138.8)
Adults: Mean BMI (Range) 22.1
(14.5–32.0)
Mean FEV1 (Range) 71 (18–134)
% pancreatic insufficient 94
% diabetes 19
% CF-related liver disease 6.5
% prescribed tube feeding 5
% prescribed food supplements 27
% prescribed steroids 11
% food allergies 5
Abbreviations:
FEV1: forced expired volume in 1 s percent predicted.
BMI: body mass index.
% WFH: percentage weight for height.
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to an item assessing non-adherence to enzymes and insulin for
weight control purposes.
3.1.2. Literature review
Two items were added to the measure (‘I pretend to others
that I have eaten’, ‘I feel guilty after eating’) based on the
literature review. These were concepts assessed in existing
measures of disturbed EABs that the research team felt would
be valuable to assess in CF. No additional relevant CF-related
EABs were identified.Fig. 2. Scree plot for 13.2. Cognitive interviewing study: piloting of amended CFEAB
measure #1
Following the cognitive interviews, small wording changes
were made to 5 items. For example, ‘When others pressure me
to eat, I don't feel like eating’ was changed to ‘I don't feel like
eating when others tell me to eat’ and ‘I only feel happy with
myself when I am thin’ was changed to ‘I feel I need to be thin
to be happy with myself’. The item assessing non-adherence to
enzymes, insulin or gastrostomy feeds for weight control was
made into 3 separate items assessing ‘enzymes’, ‘insulin’, and
‘extra feeds or supplements’.
3.3. Psychometric study: administration of amended CFEAB
measure #2 to a large sample
3.3.1. Psychometric properties
Less than 5% of data was missing on each variable and its
distribution appeared random. Therefore, mean substitution for
missing data was used for normally distributed variables and
median substitution for non-normal distributions [23]. Data met
all requirements for factor analysis suggested by Tabachnick
and Fidell [24] and Field [23]. Principal components analysis
(PCA) was used over exploratory factor analysis since this is
more appropriate for a novel measure with no existing empirical
theory regarding the structure of relationships between items
[25].
The PCAs were carried out in rounds, with the analysis re-
run if any item was deleted. Three factors were extracted based
on the scree plot (Fig. 2); although four eigenvalues were above
1 throughout the PCAs, the fourth was always only a little
above 1 (1.06–1.22 depending on the round) and accounted for
a maximum of 5% of variance in the data. Oblique rotations
were used throughout since these best approximated simple
structure and at least one of the correlations between factorsst round of PCA.
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variable, loading onto Factors 1 and 3 with loadings greater
than 0.4 (an appropriate cut-off given existing recommendations
and the current sample size [23,24,26]). Complex variables make
interpretation of factors more ambiguous [24] and this item was
deleted from the measure. All other items then loaded onto one
factor each.
Prior to interpretation of this structure, Cronbach's alpha
analyses were carried out to examine the reliability of subscales
suggested by the factors and the total measure. Standardised
alpha was used when means and/or variances of items being
assessed appeared substantially different. ‘Alpha if item deleted’
values were examined to identify candidate items for exclusion.
Alpha values for Factors 1 and 2 could not be improved by
deleting any items. One item was deleted from Factor 3 since its
deletion raised alpha from 0.77 to 0.80 and the item appeared to
access a slightly different construct to other items on the subscale
(see Table 2). Following this, alpha for Factor 3 was further
improved (0.80 to 0.83) by the deletion of another item also
appearing to access a different construct. Final alpha values for
subscales were 0.92, 0.84 and 0.83, respectively, and 0.90 for the
whole measure. Items retained in the final measure and their
factor loadings along with factor eigenvalues and amount of
variance in the data accounted for are displayed in Table 2. All
communalities were greater than 0.37 [23].
3.4. Factor interpretation
It seemed clear that Factor 1 accessed a number of cognitions
and behaviours related to weight loss and the pursuit or value of
thinness; this factor was named ‘Desire for thinness and weight
loss’. It is of note that items 15 and 21 displayed considerablyTable 2
Items loading onto each factor and their factor loadings, factor eigenvalues and amo
Factor Items
1 2. I want to be thinner
3. I cut down on food to lose weight
6. I am afraid of becoming fat
14. I would like to eat less to lose weight
15. I spend time wishing I weighed more a
17. I feel I am too fat
18. I exercise as a way to lose weight
19. I feel I need to be thin to be happy with myself
21. Gaining weight makes me feel happy a
22. I eat low fat or low sugar foods so I won't gain weight
2 8. The thought of eating food makes me feel worried
10. So I won't gain weight, I deliberately don't take my enzymes
11. So I won't gain weight, I deliberately don't take my insulin
12. So I won't gain weight, I deliberately don't take my extra feeds or s
16. I make myself vomit (sick) after I eat to control my weight
20. I am put off eating because my CF makes me feel sick
23. I pretend to others that I have eaten
24. I feel guilty after eating
3 1. I enjoy eating a
9. I feel full quickly
13. I have a good appetite for food a
Deleted items (reason): 4. I find it hard to gain weight (complex variable), 5. I don't
Even if I feel unwell, I try to eat something** (deletion improved subscale alpha).
a Negatively scored items.different distributions compared to other items on this factor,
with a median and mean (Item 15 was non-normally distributed
and Item 21 normally distributed) of 4 and 2.2 respectively,
compared to all other items with medians of 0 (see Table 3). This
appears to be related to characteristics of the current sample,
where many participants were not underweight (see Table 1),
and thus may not indicate that they ‘spend time wishing they
weighed more’ (Item 15) or ‘feel happy when they gained
weight’ (Item 21) on these negatively scored items.
Factor 2 seemed to access a mix of CF-specific EABs (Items
10–12 and 20) and EABs that may be related to eating-disordered
psychopathology (Items 16 and 24) or perhaps to CF-related
phenomenology (Items 8 and 23). All of these items were also
extremely positively skewed with more than 75% of the sample
responding ‘Never’ and any score greater than 0 classed as an
outlier [27]; only one other item (Item 22) displayed such a
skewed distribution although most items were positively skewed
(see Table 3). This factor was provisionally named ‘Disturbed
EABs’ to reflect the more ‘extreme’ and ‘disturbed’ nature of
attitudes and behaviours on this factor, which were also very
uncommon in the study population.
It seemed clear that the three items on Factor 3 (I enjoy
eating, I feel full quickly, I have a good appetite for food) were
assessing concepts around appetite for food and this was named
‘Appetite’.
4. Discussion
The expert evaluation and cognitive interview components of
the study identified a number of amendments to the CFEAB
measure, including the deletion of nine items, to enhance
its content validity, acceptability and ease of completion forunt of variance accounted for.
Factor loading Eigenvalue Variance accounted for (%)
.917 7.75 36.90
.732
.764
.861
.570
.896
.583
.831
.697
.707
.554 3.86 18.40
.614
.733
upplements .909
.904
.466
.601
.645
.871 1.85 8.80
.774
.840
feel like eating when others tell me to eat (deletion improved subscale alpha), 7.
Table 3
Descriptive statistics for individual items on the final CFEAB measure.
Item Median Percentiles
25′ 75′
1 0 0 1
2 0 0 2
3 0 0 1
6 0 0 1
8 0 0 0
9 1.46 a 1.06 b
10 0 0 0
11 0 0 0
12 0 0 0
13 1 0 1
14 0 0 1
15 4 2 4
16 0 0 0
17 0 0 1
18 0 0 1
19 0 0 1
20 0 0 0
21 2.2 a 1.47 b
22 0 0 0
23 0 0 0
24 0 0 0
a Mean.
b Standard deviation.
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review, the CFEAB measure's target constructs (EABs related to
EDs and to CF) appeared to be adequately sampled. After
administering the amended CFEAB measure to a large sample of
people with CF attending routine clinics, a three-factor solution
explaining an adequate 64% of variance in the data was found
[28]; this was interpreted as ‘Desire for thinness and weight loss’
(10 items), ‘Disturbed EABs’ (8 items) and ‘Appetite’ (3 items).
Three items were deleted due to complex factor loadings or
because their deletion improved subscale alpha. Internal con-
sistencies of all CFEAB subscales and the overall measure were
above the recommended cut-off of 0.70, with values for the whole
measure and Factors 1 and 2 classified as ‘Very Good’ [18].
A clear CF-related EABs factor did not emerge. Five EABs
related to disruptions in normal appetite reported in CF or
pressure from others to eat loaded onto Factor 3 (‘Appetite’),
although two of these were deleted following internal consistency
analyses. Four remaining EABs that directly referenced CF or its
treatments (Items 10, 11, 12 and 20) loaded onto the second
factor, although were accompanied by other EABs more
indicative of EDs. Factor 2 was named ‘Disturbed EABs’ in an
attempt to summarise this range of constructs that also displayed
a floor effect in the study population; however, it will be helpful
to further investigate the nature of this factor in future construct
validity analyses, described below.
Distributions of the vast majority of items (19 out of 24) on the
CFEAB measure were positively skewed, particularly those on
Factor 2, with many outlying observations identified. Although
some authors [29,30] suggest outlying scores can have an undue
influence on the factor solution, a satisfactory solution was
attained. However, it is possible this is unstable and replication of
the factor structure needs to be investigated in other CF samples,particularly those where greater variability in scores may be
observed (i.e. patients with identified problems with eating).
The fact that CFEAB items have not demonstrated ‘desirable’
psychometric properties of a relatively high variance and mean
close to the centre of the range of possible scores [18] does not
detract from the potential clinical utility of the measure. That is,
the measure will be helpful in identifying any disturbance in
EABs associated with weight loss or low weight maintenance in
people with CF, given the negative health implications of this.
The low prevalence of disturbed EABs found within this com-
munity CF sample is also consistent with the lower prevalence of
EDs [1] and disturbed EABs [2,4,5] found in CF compared to
control samples.
It is possible that the lack of control over when the measure
was completed during clinic visits may have introduced bias, for
example, a minimising of disturbances in EABs if completed
after seeing a dietician where problems with nutritional status
were discussed or an increased desire for thinness after being
weighed. More generally, as described in the general population
[31], some participants may have been reluctant to disclose
disturbed EABs due to a lack of complete response anonymity
(there was face-to-face contact with researchers to promote
recruitment rates).
The next stage in the development of the CFEABmeasure will
be to examine its construct validity and that of the subscales. This
will involve comparing the CFEAB measure with existing
measures of DEABs related to EDs [i.e. 10–12] including
diagnostic interviews for EDs [32], weight/BMI, health indicators
and other related psychological variables (i.e. mood, self-esteem,
quality-of-life). Group comparisons using participants with EDs,
CF and EDs or CF and ‘eating problems’ identified by the clinical
team may be useful along with the comparison of scores and
CFEAB factor structure between males and females and
adolescents and adults. The use of cut-offs for total or subscale
CFEAB scores to identify likely disturbances in EABs and
qualitative descriptions of CFEAB scores based on normative
values in the CF population could also be investigated.
4.1. Implications for practice
The CFEAB measure has demonstrated good psychometric
properties and, once validated, may be used to identify dis-
turbances in EABs in patients with CF in need of further
assessment. Further guidance regarding interpretation of CFEAB
scores, particularly concerning indicators for treatment (i.e. referral
to specialist ED team, management by in-house CF team), can be
given following validation. This will help ensure the CFEAB
measure can be administered by any member of the CF team, not
just psychosocial professionals. The nature of EDs and CF-related
EABs in CF and the efficacy of interventions for these also need to
be further investigated before the CFEAB measure can be used to
reliably inform evidence-based treatments.
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